Influvac

Medicinal product

(Invented) name

Influvac

Active substance (s)

A/Victoria/4897/2022 (H1N1)pdm09 panaši padermė (A/Victoria/4897/2022 IVR‐238)/A/Croatia/10136RV/2023 (H3N2) – panaši padermė (A/Croatia/10136RV/2023, X-425A)/B/Austria/1359417/2021 panaši padermė (B/Austria/1359417/2021, BVR-26)

Strength

15 µg/15 µg/15 µg/dozėje

Pharmaceutical form

injekcinė suspensija užpildytame švirkšte

Route (s) of administration

leisti į raumenis, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J07BB02, influenza, inactivated, split virus or surface antigen

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-07-08

Date of renewal

Documents

3518_Influvac inj_susp_uzpil_sv_PL_2026-10-14_K.docx

3518_Influvac inj_susp_uzpil_sv_PZ_2026-10-14_K.docx

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Dozėje (0,5 ml) yra:	0.5 ml
A/Victoria/4897/2022 (H1N1)pdm09 panaši padermė (A/Victoria/4897/2022 IVR‐238)	15 µg
A/Croatia/10136RV/2023 (H3N2) – panaši padermė (A/Croatia/10136RV/2023, X-425A)	15 µg
B/Austria/1359417/2021 panaši padermė (B/Austria/1359417/2021, BVR-26)	15 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
121470	107577	1107577	užpildytas švirkštas	0,5 ml N1 (su adata)		Receptinis	LT/L/26/3518/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-07-08	Registruotas